
1. j trop dis public health. 2018;6(2):259. doi: 10.4172/2329-891x.1000259. epub
2018 apr 8.

sickle cell disease clinical trials phenotypes.

ezekekwu ca(1), kotila tr(1), akingbola ts(1), lettre g(2), gordeuk vr(3), cooper
rs(4), debaun mr(5), inusa b(6), tayo bo(4); africa sickle cell research network.

author information: 
(1)department hematology, college medicine, university ibadan, ibadan,
nigeria.
(2)montreal heart institute, montr√©al, qc h1t 1c8, canada.
(3)division hematology & oncology, department medicine, university of
illinois chicago, chicago, il, usa.
(4)department public health sciences, loyola university chicago stritch school
of medicine, maywood, il, usa.
(5)guy's st. thomas foundation trust, london, united kingdom.
(6)division hematology/oncology, department pediatrics, vanderbilt meharry,
center excellence sickle cell disease, children's hospital vanderbilt,
nashville, usa.

sickle cell disease, one world's common genetic disorders is
prevalent sub-saharan africa. trans-atlantic slave trade accounted the
gene movement africa caribbean united states america and
lately, migration resulted introduction gene united
kingdom parts europe. different haplotypes exist, however the
differences haplotypes sufficient explain different
clinical variations within region different settings.

doi: 10.4172/2329-891x.1000259 
pmcid: pmc6219473
pmid: 30410998 

